- •Mistral Large 2512 argues HOLD because The original thesis for AVGO remains intact despite the post-earnings drawdown. The removal of the binary earnings catalyst and the shift to a calm/bullish regime provide a more favorable backdrop for a rebound. Price is currently testing critical support at $350.07, and if this level holds, the path to reclaiming the $359.42 resistance and advancing toward the $386 target remains viable. Historical win rates and fundamentals still support the long case.
- •DeepSeek V4 Flash argues EXIT because The original thesis is invalidated: the binary earnings catalyst resolved negatively with a Q4 revenue guidance miss, price has broken below both the $362 support and the $358 stop, and momentum is deteriorating with no sign of stabilization. The stock is showing idiosyncratic weakness (XLK flat, AVGO -4%) driven by a fundamental guidance disappointment that cannot be quickly repaired. Continuing to hold a position that has already breached its stop and lost its catalyst thesis exposes capital to further downside toward the next support at $336.75.
- •What changed: Earnings released Sept 2: Q4 revenue guidance of ~$34.8B missed $35.05B consensus, stock gapped down -4.6% to $351.92, breaking below original support ($362) and stop ($358). Momentum reversed from improving to deteriorating (4h RSI fell from 44.8 to 31.87).
The original thesis for AVGO remains intact despite the post-earnings drawdown. The removal of the binary earnings catalyst and the shift to a calm/bullish regime provide a more favorable backdrop for a rebound. Price is currently testing critical support at $350.07, and if this level holds, the path to reclaiming the $359.42 resistance and advancing toward the $386 target remains viable. Historical win rates and fundamentals still support the long case.
The original thesis is invalidated: the binary earnings catalyst resolved negatively with a Q4 revenue guidance miss, price has broken below both the $362 support and the $358 stop, and momentum is deteriorating with no sign of stabilization. The stock is showing idiosyncratic weakness (XLK flat, AVGO -4%) driven by a fundamental guidance disappointment that cannot be quickly repaired. Continuing to hold a position that has already breached its stop and lost its catalyst thesis exposes capital to further downside toward the next support at $336.75.
The original thesis is invalidated: the Sept 2 earnings catalyst — the pivot of the trade — resolved negatively with a Q4 revenue guide below consensus, gapping AVGO ~5-6% lower and driving it through both the $358 stop and the $362 support that anchored the setup. Momentum has fully reversed (daily RSI 35 falling, price below every SMA), sector confirmation has flipped to contradiction (XLK +0.19% vs AVGO -4.01%), and the $386 target now requires reclaiming ~$34 of dense overhead with no acceptance. The exact earnings-gap failure named in the entry premortem has occurred, so the position should be closed.
- →The original thesis was based on stabilizing above 4h support at $362.01 with improving momentum ahead of earnings. While the earnings event has passed, the current price is testing a lower support level at $350.07, and momentum has weakened. The regime shift to calm/bullish aligns with the original thesis direction, but the technical structure has deteriorated, requiring a reclaim of $359.42 to restore the original path.
- →The original thesis for AVGO remains intact despite the post-earnings drawdown. The removal of the binary earnings catalyst and the shift to a calm/bullish regime provide a more favorable backdrop for a rebound. Price is currently testing critical support at $350.07, and if this level holds, the path to reclaiming the $359.42 resistance and advancing toward the $386 target remains viable. Historical win rates and fundamentals still support the long case.
Individual Model Review
The original thesis is invalidated: the Sept 2 earnings catalyst — the pivot of the trade — resolved negatively with a Q4 revenue guide below consensus, gapping AVGO ~5-6% lower and driving it through both the $358 stop and the $362 support that anchored the setup. Momentum has fully reversed (daily RSI 35 falling, price below every SMA), sector confirmation has flipped to contradiction (XLK +0.19% vs AVGO -4.01%), and the $386 target now requires reclaiming ~$34 of dense overhead with no acceptance. The exact earnings-gap failure named in the entry premortem has occurred, so the position should be closed.
Stop breached ($351.92 vs $358 stop) and the binary earnings catalyst resolved against the position with a below-consensus Q4 revenue guide, gapping the stock through the $362 original support. The entry-time premortem failure mechanism has fully materialized and the $386 target path is no longer feasible within the remaining horizon.
The original thesis is invalidated: the Sept 2 earnings catalyst — the pivot of the trade — resolved negatively with a Q4 revenue guide below consensus, gapping AVGO ~5-6% lower and driving it through both the $358 stop and the $362 support that anchored the setup. Momentum has fully reversed (daily RSI 35 falling, price below every SMA), sector confirmation has flipped to contradiction (XLK +0.19% vs AVGO -4.01%), and the $386 target now requires reclaiming ~$34 of dense overhead with no acceptance. The exact earnings-gap failure named in the entry premortem has occurred, so the position should be closed.
▼ Click to expandA hold case rests on price stabilizing at the $350 4h support with the regime having flipped to calm/bullish, the above-estimate $21.7B AI chip guidance, and a historically favorable long win rate (59.8%) that could fuel a mean-reversion bounce back toward the SMA cluster. Institutional ownership of 80.2% and a 33 short-volume percentile suggest limited forced-selling pressure remaining.
▼ Click to expandThe original thesis is invalidated: the binary earnings catalyst resolved negatively with a Q4 revenue guidance miss, price has broken below both the $362 support and the $358 stop, and momentum is deteriorating with no sign of stabilization. The stock is showing idiosyncratic weakness (XLK flat, AVGO -4%) driven by a fundamental guidance disappointment that cannot be quickly repaired. Continuing to hold a position that has already breached its stop and lost its catalyst thesis exposes capital to further downside toward the next support at $336.75.
Stop breached at $358, original support $362 lost, earnings catalyst resolved against the position with Q4 guidance miss, momentum deteriorating, and idiosyncratic weakness confirmed by sector divergence.
The original thesis is invalidated: the binary earnings catalyst resolved negatively with a Q4 revenue guidance miss, price has broken below both the $362 support and the $358 stop, and momentum is deteriorating with no sign of stabilization. The stock is showing idiosyncratic weakness (XLK flat, AVGO -4%) driven by a fundamental guidance disappointment that cannot be quickly repaired. Continuing to hold a position that has already breached its stop and lost its catalyst thesis exposes capital to further downside toward the next support at $336.75.
▼ Click to expandThe post-earnings selloff may be an overreaction to a modest guidance miss — AI chip guidance of ~$21.7B actually beat the $21.33B estimate, and Q3 results beat on both revenue and EPS. The regime has shifted to calm/bullish, which could provide a supportive macro backdrop for a recovery. Price is approaching the 4h support at $350.07 and the daily lower Bollinger Band at $332.51, which may attract dip-buyers.
▼ Click to expandThe original thesis for AVGO remains intact despite the post-earnings drawdown. The removal of the binary earnings catalyst and the shift to a calm/bullish regime provide a more favorable backdrop for a rebound. Price is currently testing critical support at $350.07, and if this level holds, the path to reclaiming the $359.42 resistance and advancing toward the $386 target remains viable. Historical win rates and fundamentals still support the long case.
The original thesis for AVGO remains intact despite the post-earnings drawdown. The removal of the binary earnings catalyst and the shift to a calm/bullish regime provide a more favorable backdrop for a rebound. Price is currently testing critical support at $350.07, and if this level holds, the path to reclaiming the $359.42 resistance and advancing toward the $386 target remains viable. Historical win rates and fundamentals still support the long case.
▼ Click to expandThe exit case for AVGO is grounded in the failure to hold above the stop level of $358.00 and the weak technical structure. Price is below key support levels, and momentum is declining, as evidenced by falling RSI and MACD histogram. The cross-asset divergence and post-earnings weakness suggest idiosyncratic risk that could invalidate the original thesis if support at $350.07 breaks.
▼ Click to expandRun Summary
Intraday discovery triggered reanalysis on AVGO. Verdict: EXIT (2/3 EXIT). Conviction: 48.